Stratalycs Technologies is a genomics-driven research and analytics company delivering high-impact biological insights through next-generation sequencing (NGS), advanced bioinformatics, and AI-powered data science. Our research accelerates discovery across healthcare, biotechnology, agriculture, and environmental sciences.
Our Genomics Research Focus
We specialize in converting complex genomic data into actionable scientific and clinical insights through reproducible, scalable, and secure research pipelines.
Our research domains include:
-
Human Genomics & Precision Medicine
-
Cancer & Disease Genomics
-
Transcriptomics & Functional Genomics
-
Population & Comparative Genomics
-
Agricultural & Microbial Genomics
Genomic Technologies We Use
We apply state-of-the-art sequencing and computational platforms:
Sequencing & Assays
-
Whole Genome Sequencing (WGS)
-
Whole Exome Sequencing (WES)
-
RNA-Seq (Bulk & Single-Cell)
-
Metagenomics & Microbiome Analysis
-
Epigenomics (Methylation & Chromatin Studies)
Bioinformatics & AI
-
Variant discovery & annotation
-
Differential gene expression analysis
-
Pathway & network analysis
-
Machine learning-based biomarker discovery
-
Multi-omics data integration
Precision Medicine & Clinical Research
Our genomics research supports personalized healthcare by enabling:
-
Disease-specific biomarker identification
-
Pharmacogenomics for optimized drug response
-
Risk prediction and patient stratification
-
Translational genomics for clinical decision support
We collaborate closely with clinicians, diagnostic labs, and research hospitals.
Genomics Beyond Healthcare
Stratalycs Technologies also applies genomics to:
-
Crop improvement & stress-resistant breeding
-
Microbial genomics for soil & gut health
-
Environmental DNA (eDNA) biodiversity studies
-
Sustainable agriculture & ecosystem monitoring
Research Integrity & Compliance
We follow global best practices:
-
Ethical research frameworks
-
Secure data handling & privacy
-
Reproducible pipelines
-
International data standards
👉 Partner with Stratalycs Technologies to advance genomics research.